Medicare IVIG Access Act of 2008

H.R. 2900/S. 1082, Prescription Drug User Fee Amendments of 2007, all issues as they relate to pedigree, anti-counterfeiting and importation of biologics, prescription drugs and medical products H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008 S. 1695, Biologics Price Competition and Innovation Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 2914/S. 2990, Medicare IVIG Access Act of 2007 P.L. 110-85/H.R. 3580, Food and Drug Administration Amendments Act of 2007 H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 3610, the Food and Drug Import Safety Act of 2007 S. 3408, Comparative Effectiveness Research Act of 2008 Food and Drug Administration Globalization Act of 2008 Drug and device marketing and promotion Drug and biological product pricing and reimbursement Healthcare-acquired infections Lifetime caps for insurance Medical product safety Prescription drug pedigree and anti-counterfeiting policy

Client expense: $620,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Medicare and Medicaid Coverage/Reimbursement for Intravenous Immune Globulin (IVIG) HR. 2914: Medicare IVIG Access Act (Reimbursement for IVIG)/ S. 2990 Medicare IVIG Access Act HR. 1282: Medigap Access Improvement Act ( Medigap insurance expansion)

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare and Medicaid reimbursement issues for certain drugs and biologics; all issues related to Medicare coverage of pre-ESRD education. H.R. 2914 / S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services. S. 558, Mental Health Parity Act, as it pertains to Medicaid rebates; H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act, as it pertains to Medicaid rebates, Medicare reimbursement issues.

Client expense: Not reported · Firm income: $57,500

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

HR. 2914: Medicare IVIG Access Act / HR. 2770: Medicare Part B Prompt-Pay exclusion from Average Sales Price Medicare/Medicaid coverage and reimbursement for Intravenous Immune Globulin (IVIG) S. 2990: Medicare IVIG Access Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Part D, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Competitive Acquuisition Program for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 2567 and S 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2914 and S 2990 - Medicare IVIG Access Act of 2008; all aspects

Client expense: $780,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Health Information Technology, Electronic Prescribing, Comparative Effectiveness, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Carve-out of Generic Drugs from State Generic Substituion Laws HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S. 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2008; all aspects HR 2914 and S 2990 - Medicare IVIG Access Act of 2007; all aspects HR 3800 - Promoting Health Information Technology Act; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 6357- Protecting Records, Optimizing Treatment and Easing Communcations through Healthcare Technology PRO(TECH)T Act of 2008; all aspects HR 6898 - Health-e-Information Technology Act of 2008; all aspects S 976 - Genomics and Personalized Medicine Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S. 1814 - Health Information Privacy and Security Act; all aspects

Client expense: $780,000 · Firm income: Not reported

HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 1432 and S. 316 - Preserve Access to Afforadable Generics Act; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects HR 2567 and S. 3505 and S. 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2008; all aspects HR 2914 and S. 2990 - Medicare IVIG Acces Act of 2007; all aspects HR. 3800 - Promoting Health Information Technology Act; all aspects HR 5629 - Pathway for Biosimilars Act; all aspects HR 6357 - Protecting Records, Optimimizing Treatment and Easing Communications through Healthcare Technology (PRO[TECH]HIT) Act of 2008; all aspects HR 6898 - Health-e-Information Technology Act of 2008; all aspects S 976 - Genomics and Personlized Medicine Act of 2007; all aspects S 1408 - Health Information Technology Act of 2007; all aspects S 1693 - Wired for Health Care Quality Act; all aspects S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects S 1814 - Health Information Privacy and Security Act; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Part D, Antitrust Exemption for Independent Pharmacies, IVIG Payments, Medicare Demonstration Projects for Durable Medical Equipment HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects HR 2567 and S. 3505 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects HR 2914 and S 2990 - Medicaer IVIG Access Act of 2008; all aspects

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

General issues regarding Medicare and Medicaid; HR 2914, S 2990, regarding intravenous immunoglobulin (IVIG); HR 6331 and S 3101, regarding Medicare improvements for patients and providers; S 558, HR 1424, Mental Health Parity, as it relates to Medicaid rebate

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare IVIG Access Act, HR 2914 and S. 2990.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1245/S. 432, Kidney Disease Educational Benefits Act of 2007 regarding Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education H.R. 1193/S. 691, The Kidney Care Quality and Improvement Act of 2007 regarding all issues related to Medicare coverage of pre-ESRD education H.R. 2914/S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 6331/S. 3101, Medicare Improvements for Patients and Providers Act, as it relates to pre-dialysis education for certain Medicare beneficiaries S. 3118, Preserving Access to Medicare Act of 2008, as it relates to pre-dialysis education for certain Medicare beneficiaries S. 558, Mental Health Parity Act of 2007, as it relates to Medicaid rebates H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007, as it relates to Medicaid rebates Drug and biological product pricing and reimbursement Durable Medical Equipment (DME) payment Product Payment Issues Therapy Payment Issues

Client expense: $720,000 · Firm income: Not reported

H.R. 2900/S. 1082, Prescription Drug User Fee Amendments of 2007, all issues as they relate to pedigree, anti-counterfeiting and importation of biologics, prescription drugs and medical products H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008 S. 1695, Biologics Price Competition and Innovation Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 2914/S. 2990, Medicare IVIG Access Act of 2007 P.L. 110-85/H.R. 3580, Food and Drug Administration Amendments Act of 2007 H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 3610, the Food and Drug Import Safety Act of 2007 S. 3408, Comparative Effectiveness Research Act of 2008 Food and Drug Administration Globalization Act of 2008 Drug and device marketing and promotion Drug and biological product pricing and reimbursement Healthcare-acquired infections Lifetime caps for insurance Medical product safety Prescription drug pedigree and anti-counterfeiting policy

Client expense: $720,000 · Firm income: Not reported

Antitrust H.R.971/S.885: Community Pharmacy Fairness Act of 2007 S.2161: Community Pharmacy Fairness Act of 2007 Pharmacy Reimbursement H.R.1474: Fair and Speedy Treatment of Medicare Dug Claims Act S.1954: Pharmacy Access Improvement Act of 2007 Medicare Part B H.R.2914/S.2990: medicare IVIG Access Act Medicare Competitive Bidding H.R.6252/S.3144: Medicare DMPEOS Competitive Acquisition Reform Act E-Prescribing S.2408: medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 Physician SGR Fix H.R.6331/S.3101: Medicare Improvements for Patients and Providers Act

Client expense: Not reported · Firm income: $80,000

Medicare and Medicaid Coverage/Reimbursement for Intravenous Immune Globulin (IVIG) HR. 2914: Medicare IVIG Access Act (Reimbursement for IVIG)/ S. 2990 Medicare IVIG Access Act HR. 1282: Medigap Access Improvement Act ( Medigap insurance expansion) HR. 6331: Medicare Improvement For Patients and Providers Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Antitrust H.R.971/S.885: Community Pharmacy Fairness Act of 2007 S.2161: Community Pharmacy Fairness Act of 2007 Pharmacy Reimbursement H.R.1474: Fair and Speedy Treatment of Medicare Dug Claims Act S.1954: Pharmacy Access Improvement Act of 2007 Medicare Part B H.R.2914/S.2990: medicare IVIG Access Act Medicare Competitive Bidding H.R.6252/S.3144: Medicare DMPEOS Competitive Acquisition Reform Act E-Prescribing S.2408: medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007 Physician SGR Fix H.R.6331/S.3101: Medicare Improvements for Patients and Providers Act

Client expense: Not reported · Firm income: $80,000

HR. 2914: Medicare IVIG Access Act/ HR. 2770: Medicare Part B Prompt-Pay exclusion from Average Sales Price Medicare/Medicaid coverage and reimbursement for Intravenous Immune Globulin (IVIG) S. 2990: Medicare IVIG Access Act HR. 6331: Medicare Improvement for Patients and Providers Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid pharmacy reimbursement; Medicare reimbursement for IVIG, including provisions in H.R. 2914 and S. 2990 The Medicare IVIG Access Act

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education (S. 432/H.R. 1245, Kidney Disease Education Benefits Act of 2007; S. 691/H.R. 1193 Kidney Care Quality and Improvement Act of 2007); all issues related to Medicare coverage of pre-ESRD education. H.R. 2914 / S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services; H.R. 6331 / S. 3101, Medicare Improvements for Patients and Providers Act, as it pertains to pre-dialysis education for certain M-care beneficiaries; S. 3118, Preserving Access to Medicare Act, as it pertains to pre-dialysis education for certain M-care beneficiaries: S. 558, Mental Health Parity Act, as it pertains to Medicaid rebates; H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act, as it pertains to Medicaid rebates, Medicare reimbursement issues.

Client expense: Not reported · Firm income: $57,500

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

General issues regarding Medicare and Medicaid; Hr 2914, S 2990, regarding intravenous immunoglobulin (IVIG); HR 6331 and S 3101, regarding Medicare improvements for patients and providers; S 558, HR 1424, Mental Health Parity, as it relates to Medicaid rebate

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education (S. 432/H.R. 1245, Kidney Disease Education Benefits Act of 2007; S. 691/H.R. 1193 Kidney Care Quality and Improvement Act of 2007); all issues related to Medicare coverage of pre-ESRD education. H.R. 2914 / S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services; H.R. 6331 / S. 3101, Medicare Improvements for Patients and Providers Act, as it pertains to pre-dialysis education for certain M-care beneficiaries; S. 3118, Preserving Access to Medicare Act, as it pertains to pre-dialysis education for certain M-care beneficiaries: S. 558, Mental Health Parity Act, as it pertains to Medicaid rebates; H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act, as it pertains to Medicaid rebates.

Client expense: Not reported · Firm income: $57,500

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 3101 and H.R. 6331, the Medicare Improvements for Patients Providers Act of 2008. S. 2914 and S. 2990, Medicare IVIG Access Act of 2007.

Client expense: Not reported · Firm income: $70,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1245/S. 432, Kidney Disease Educational Benefits Act of 2007 regarding Medicare and Medicaid reimbursement issues including Medicaid Rebate and Kidney Disease Education H.R. 1193/S. 691, The Kidney Care Quality and Improvement Act of 2007 regarding all issues related to Medicare coverage of pre-ESRD education H.R. 2914/S. 2990, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 6331/S. 3101, Medicare Improvements for Patients and Providers Act, as it relates to pre-dialysis education for certain Medicare beneficiaries S. 3118, Preserving Access to Medicare Act of 2008, as it relates to pre-dialysis education for certain Medicare beneficiaries S. 558, Mental Health Parity Act of 2007, as it relates to Medicaid rebates H.R. 1424, Paul Wellstone Mental Health and Addiction Equity Act of 2007, as it relates to Medicaid rebates Drug and biological product pricing and reimbursement Durable Medical Equipment (DME) payment Product Payment Issues Therapy Payment Issues

Client expense: $900,000 · Firm income: Not reported

H.R. 2900/S. 1082, Prescription Drug User Fee Amendments of 2007, all issues as they relate to pedigree, anti-counterfeiting and importation of biologics, prescription drugs and medical products H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008 S. 1695, Biologics Price Competition and Innovation Act of 2007 H.R. 5629, Pathway for Biosimilars Act H.R. 2914/S. 2990, Medicare IVIG Access Act of 2007 P.L. 110-85/H.R. 3580, Food and Drug Administration Amendments Act of 2007 H.R. 5605/S. 2029, Physician Payments Sunshine Act of 2007 H.R. 3610, the Food and Drug Import Safety Act of 2007 Food and Drug Administration Globalization Act of 2008 Drug and device marketing and promotion Drug and biological product pricing and reimbursement Healthcare-acquired infections Lifetime caps for insurance Medical product safety Prescription drug pedigree and anti-counterfeiting policy

Client expense: $900,000 · Firm income: Not reported

Medicare and Medicaid Coverage/Reimbursement for Intravenous Immune Globulin (IVIG) HR 2914: Medicare IVIG Access Act (Reimbursement for IVIG)/ S 2990 Medicare IVIG Access Act HR 1282: Medigap Access Improvement Act (Medigap insurance expansion) HR 6331 :Medicare Improvement For Patients and Providers Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicaid pharmacy reimbursement; Medicare reimbursement for IVIG, including provisions in H.R. 2914 and S. 2990 The Medicare IVIG Access Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2914: Medicare IVIG Access Act Medicare/Medicaid coverage and reimbursement for Intravenous Immune Globulin (IVIG) S 2990: Medicare IVIG Access Act HR 6331: Medicare Improvement for Patients and Providers Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE